The global Fibrinolytic Therapy Market is estimated to be valued At US$ 34.96 Billion In 2023 and is expected to exhibit a CAGR Of 3.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Fibrinolytic therapy involves the use of drugs to dissolve blood clots in patients with cardiovascular diseases such as heart attacks, pulmonary embolism, and ischemic stroke. This ... Read more
